We are live on
!
Find out more
TGI
TRV GP II Portfolio holdings
AUM
$1.34M
1-Year Est. Return
67.55%
This Fund
S&P 500
This Quarter
Est. Return
-36.53%
1 Year Est. Return
-67.55%
3 Year Est. Return
-20.84%
5 Year Est. Return
-49.87%
10 Year Est. Return
–
AUM
$93.1M
AUM Growth
-$3.81M
(-3.9%)
Cap. Flow
+$52.9M
Cap. Flow
% of AUM
56.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$52.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
IVAV
VM
CL
GAM
MC
NC
HCIG
NP
TRV GP II's Q1 2020 Portfolio in Review
As of Q1 2020, TRV GP II held 3 positions worth $93.1M, down 3.9% from $96.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP II deployed $52.9M of net new capital in Q1 2020, opening 1 new position. Its largest new stake was Revolution Medicines: 1,909,317 shares worth $41.8M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP II's largest Q1 2020 buy was Revolution Medicines: 1,909,317 shares worth $41.8M.
- TRV GP II's ten largest holdings make up 100% of its $93.1M portfolio in Q1 2020.
- TRV GP II opened 1 new position and closed 0 in Q1 2020.
- TRV GP II's portfolio value fell 3.9% quarter-over-quarter to $93.1M.
Based on TRV GP II's 13F filing for Q1 2020, filed 11 May 2020.